FBT ETF (First Trust NYSE Arca Biotechnology Index Fund) is managed by First Trust Portfolios (US) with $2.63B in net assets. FBT expense ratio is 0.54%, holding 31 positions across sectors including Unknown. Inception date: 2006-06-19.

FBT performance shows a YTD return of 10.17%. The 1-year return is 38.30% and the 5-year return is 6.61%.

FBT top holdings include Corcept Therapeutics Inc (7.7%), BeiGene Ltd (5.2%), Intra-Cellular Therapies Inc (4.7%), CORT (4.0%), NEO (4.0%). View all FBT holdings, sector breakdown, or dividend history.

FBT can be compared against other funds using the overlap calculator or side-by-side comparison tool. FBT alternatives are available via the screener, along with tax-loss harvesting opportunities.